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Nutrition is defined as the process of pro-
viding and obtaining the food necessary
for the health and growth of animals.
Food nutrients are utilized as the main
energy source by an animal via various
processes, including digestion and absorp-
tion in the digestive tract, blood transport,
and metabolism in the cells. Regulation
of animal nutrition is associated with the
functions of various tissues and organs
in animals. New and evolving concepts in
animal nutrition and metabolism present
new research challenges that require inter-
disciplinary collaboration, a rethinking of
traditional disciplinary boundaries, and
adaptation of new research methodol-
ogy. In this article, I will focus on three
of these challenges – comparative nutri-
tion, the relationship between immunol-
ogy and nutritional disease, and nutrige-
nomics – describing the development of
recent advances and promising areas for




Studies on comparative animal nutrition
begin with analysis of the processes of
energy metabolism. Energy metabolism
and imbalances in metabolic processes can
induce various diseases in animals. Energy
metabolism is the process of ATP pro-
duction. In tumor cells, energy metab-
olism processes, including the pentose
phosphate pathway and the malate aspar-
tate shuttle, are accelerated remarkably
(1), whereas, ATP production through
glycolysis decreases greatly in the tissues
of diabetic animals (2). Monitoring ATP
production in tissues is an effective way
to understand the health conditions of
animals. Further, the relationship between
energy metabolism, endocrinology, and
immunology is key to understanding meta-
bolic disorders in animals.
In recent years, lifestyle-related meta-
bolic diseases, such as obesity, hyperlipi-
demia, and diabetes mellitus have increased
in prevalence in dogs and cats, as in human
beings (3, 4). As also seen in human beings,
obesity in animals is caused by overeating
and physical inactivity, and is a risk fac-
tor for various diseases involving energy
metabolism. Obesity is defined as ectopic
lipid accumulation. Recent evidence sug-
gests that reduced lipid storage in the adi-
pose tissue of obese animals contributes
to ectopic lipid accumulation in non-
adipose tissues, such as liver, skeletal mus-
cle, and pancreas, where lipotoxicity can
impair metabolic function (5). Excess calo-
ries and physical inactivity induce hyper-
glycemia followed by increased insulin
secretion, which accelerates fatty acid syn-
thesis via activation of transcription fac-
tors, such as sterol regulatory element bind-
ing protein (SREBP)-1c. Acceleration of
fatty acid synthesis induces ectopic lipid
accumulation and increases visceral fat
accumulation (the state of obesity). These
recent findings emphasize the importance
of veterinary research in understanding
the pathogenesis and prevention of meta-
bolic disease and for developing effective
treatment.
In contrast to the detrimental effects
of lipid in obesity and diabetes, ectopic
lipid accumulation can be highly valuable
in animal nutrition, such as in the marbling
of beef. Feeding a high amount of cereal
grains, such as corn or barley (high-calorie
foods), changes the color of carcass fat from
yellowish to white, and increases the chance
of obtaining a higher quality grade of meat.
The common gene for fatty acid synthesis
between monogastric animals (dogs and
cats) and ruminants is SREBP-1c. Regu-
lation of the SREBP gene prevents occur-
rence of obesity in dogs and cats, and
induces marbling in beef cattle. Further,
the nutritional characteristics of rumen fer-
mentation in cattle differ from those in
monogastric animals like dogs and cats.
Different kinds of metabolic diseases also
are observed between companion animals
and food/agricultural animals. Compara-
tive nutrition, therefore, is an important




As the digestive tract is one of the
most important immune organs, and
adipose tissue is the biggest endocrine
organ in the animal body, immunology
and endocrinology are indispensable view-
points in the study of animal nutrition.
In obesity, marked aberration of adipokine
(adipocytokine) secretion in visceral fat
together with an imbalance in the pro-
duction of pro- and anti-inflammatory
adipokines are critical in the develop-
ment of various aspects of the meta-
bolic syndrome, such as insulin resis-
tance. Plasma hormone concentrations
can accompany changes in the immune
states of animals. Monocyte chemoattrac-
tant protein-1 (MCP-1) is secreted from
white adipose tissue in obesity and con-
tributes to tissue macrophage accumula-
tion and insulin resistance by inducing a
chronic inflammatory state (6). Adipose
tissues in obese animals are altered to
secrete other pro-inflammatory cytokines
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such as TNF-α, MCP-1, and IL-6 (7),
which cause a persistent low-grade inflam-
mation. Obesity also induces an imbal-
ance in the immune reaction of animals.
For example, vaccination is less effec-
tive in malnourished (emaciated) animals,
which cannot produce sufficient amounts
of immunoglobulins for healthy immu-
nity. As in human beings, the relation-
ship between nutrition (energy metabo-
lism) and immunology is important for
understanding the prevention and treat-
ment of metabolic disorders in animals,
including lifestyle-related diseases.
NUTRIGENOMICS
Effects of nutrients on gene expres-
sion have been studied well in recent
years. Nutrigenomics, a branch of nutri-
tional genomics, is the study of the
effects of foods and food constituents
on gene expression. Nutrigenomics has
also been described as the influence of
genetic variation on nutrition, where gene
expression or single nucleotide polymor-
phisms (SNPs) are correlated with a nutri-
ent’s absorption, metabolism, elimination,
or biological effects. Nutrigenomics has
recently emerged as an important view-
point in animal nutrition. Nutrigenomics
can lead to the development of effective
foods for many diseases in animals, for
instance, weight reducing diets that con-
tain optimal constituents for obese ani-
mals. Metabolomics is the scientific study
of chemical processes involving metabo-
lites. Specifically, metabolomics is the “sys-
temic study of the unique chemical fin-
gerprints that specific cellular processes
leave behind.” The metabolome represents
the collection of all metabolites (the end
products of cellular processes) in a bio-
logical cell, tissue, organ, or organism (8).
Measurement of metabolites in animals
with metabolic disorders can clarify the
underlying cause of the disorder, such
that metabolomics is very effective for the
diagnosis of disease in animals. Ruminant
metabolomics, the measurement of fer-
mentation products in the rumen, is very
important for investigation of health in
ruminants. Exhaustive investigation of the
effects of nutrients on plasma metabolite
concentrations will be further developed
as “nutrimetabolomics” for animals. Ani-
mal Nutrition and Metabolism encourages
nutrigenomic studies for improvement of
animal health and for development of
new diagnostic and treatment methods for
nutritional diseases.
NEW TREATMENTS FOR METABOLIC
DISORDERS
This brings us to a final challenge: devel-
oping promising treatments for metabolic
disease based on our new understanding
of the role of immunology. Early treat-
ment of metabolic disorders includes the
development of customized food, supple-
ments, and drugs. Recently, good candi-
dates of supplements and drugs for treating
obesity in human medicine were devel-
oped, and these compounds will now be
studied and utilized in veterinary medi-
cine. Licorice flavonoids, for example, have
antioxidative and anti-inflammatory activ-
ities and are very effective for treating obe-
sity in animals (9). Apoptosis inhibitor
of macrophage (AIM) is a macrophage-
derived blood protein that plays a key
role in the pathogenesis of atherosclerosis,
metabolic diseases, and obesity-associated
autoimmune diseases. The regulation of
blood AIM levels or AIM function has
the potential to serve as a next-generation
therapy against these inflammatory dis-
eases (10). AIM also may be a good can-
didate for treating metabolic disorders of
animals through the new concept of drug
development.
Animal nutrition and metabolism aims
to publish research on new and effective
drugs for various diseases of many ani-
mal species through analyses of energy
metabolism using new analytical tech-
niques, i.e., genomics, proteomics, and
metabolomics. Energy metabolism is the
origin of animal health; imbalances in
energy metabolism lead to animal disease.
Studies on animal nutrition and metabo-
lism, therefore, will benefit the health con-
ditions of various animals. Topics of inter-
est include food (nutrients), malnutrition,
vitamin deficiency, rumen fermentation,
restricted feeding, inflammation, meta-
bolic disorders, lifestyle-related illnesses
(obesity, metabolic syndrome, diabetes,
hypertension), tumors, genetic diagnosis,
and development of supplements and
drugs in animals.
While I cite only a few major chal-
lenges (comparative nutrition, nutrition–
immunology relationship, nutrigenomics)
in the immediate future of animal nutrition
and metabolism, I know that there will
be many others. With the support of the
Editorial Board and the entire Animal
Nutrition and Metabolism Community,
Frontiers in Veterinary Sciences will be
the major forum for addressing these and
other future challenges. Welcome to the
new journal and the new, innovative style
of publishing.
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